SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trickle Portfolio

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who started this subject6/18/2001 5:30:04 PM
From: nigel bates  Read Replies (1) of 1784
 
Unlisted, but interesting. Ex ceo of Hewlett Packard joined them today.

mycometrix.com

Our Vision
"Today, microfluidics is shifting the paradigm in drug discovery research much like the integrated circuit did for electronics in the 1960s. At Fluidigm, we think microfluidics will see even broader adoption -- in fields such as drug delivery, diagnostics, chemicals and power. We are thrilled to be working with some of the most respected and innovative scientists in research and development.Our vision is to arm these inspired scientists with the microfluidic tools that will realize tomorrow's scientific breakthroughs."
-- Gajus Worthington, Chief Executive Officer ...

About Fluidigm
Fluidigm Corporation, founded in 1999 as Mycometrix Corporation, is a privately-held company dedicated to delivering the promise of microfluidics through the commercialization of its proprietary microfluidic pump and valve technology. We take a novel approach to microfluidics by fabricating microscale pumps and valves directly within flexible rubber chips. This micro-plumbing allows easy and intuitive implementation of complex fluidic schemes on chips. Fluidigm's initial customer base is in the drug discovery arena, including instrument providers, pharmaceutical companies and academic researchers. Premier biophysicist Stephen Quake, Ph.D. developed the Company's core technology at the California Institute of Technology.
Fluidigm Quick Facts

* The market for microfluidics is expected to grow by over 500% in the next four years (Frost and Sullivan, April 2001)

* Fluidigm's pump and valve technology provides previously unattainable levels of microfluidic precision and control flexibility

* Collaboration with academic researchers facilitates creation of new science with Fluidigm chips

* Innovative software design tools, rapid prototyping and plug-and-play chip control systems enable user-defined systems

* Proven technology borrowed from the semi-conductor industry ensures powerful economies of scale in manufacturing

* Strong patent portfolio consisting of 5 issued patents and over 60 pending patents, including those licensed from Caltech, Harvard and Los Alamos National Laboratory

Technology Applications
Fluidigm technology has applications in the following areas of the life science industry:

* Cell based assays, including micro cell sorting
* Genomic analysis, such as DNA sizing, hybridization, sequencing, quantification, and amplification
* Protein analysis, crystallization and purification, MS-interface
* Biochemical and electrophysiological assays
* Gene expression, differential display analysis
* Integrated biological sample preparation
* Single molecule analysis

Additional Applications are envisioned in:

* Drug Delivery
* Diagnostics
* Chemical Industry
* Power Industry

 
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext